The trademark application PROGLY was filed by GRO Biosciences Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 16, 2021, and it was registered by office on September 24, 2021 without any oppositions.
The application was filed in Danish (English was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on September 2, 2024.
Goods And Services
The mark was filed in class 40 with Biomanufacturing for others, namely, processing amino acids for use in scientific and medical research, and industrial and commercial applications in the field of biotherapeutics and manufacturing services for others in the fields of pharmaceuticals and medicine, namely manufacturing of biotherapeutics, immunotherapeutics, immunomodulators, immunostimulants, immunogenics, antibodies, cell therapeutics, cells, immune cells, and T-cells..
The mark was filed in class 42 with following description of goods:
Scientific research, namely, research related to synthetic biology, chemical biology, protein design and development, viral resistance, and therapeutics for endocrine and immune regulation
Scientific research for medical purposes, namely, developing protein-based therapeutics
Developing custom proteins for use in scientific and medical research, and industrial and commercial applications in the field of biotherapeutics
Pharmaceutical research and development
Scientific and medical research in the fields of immunology, oncology, biology, biochemistry, and chemistry.